Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype

Splicing factor 3B subunit 1 (SF3B1) mutations define a distinct myelodysplastic syndromes (MDS) patient group with a relatively favourable disease course and high response rates to luspatercept. Few data are available on bone marrow phenotype beyond ring sideroblasts in this subgroup of patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Duetz, Carolien, Westers, Theresia M., in ’t Hout, Florentien E. M., Cremers, Eline M. P., Alhan, Canan, Venniker‐Punt, Bianca, Visser‐Wisselaar, Heleen A., Chitu, Dana A., de Graaf, Aniek O., Smit, Linda, Jansen, Joop H., van de Loosdrecht, Arjan A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Haematological malignancy ‐ Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252736/
https://ncbi.nlm.nih.gov/pubmed/33765355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados